Myopia And Presbyopia Treatment Market Intelligence, Prescriptive Research, Execute Growth Opportunities

Myopia (nearsightedness) is the most common cause of decreased vision in those under the age of 40, whereas presbyopia is the age-related loss of near focusing ability. Squinting, eye strain, and headaches are common symptoms of myopia and presbyopia. Eyeglasses, contact lenses, or refractive surgery can be used to correct or treat the disorders. Furthermore, ocular drops containing medication are a new therapy option for myopia and presbyopia. As presbyopia is an age-related visual impairment, one of the primary drivers driving market growth is an increasing geriatric population.

High prevalence of presbyopia is expected to boost market growth. More than 1.1 billion individuals around the world are suffering from presbyopia, out of which, one third are above 50 years of age. More than 90% of this patient pool belongs to developing countries. Hence the developing countries are expected to exhibit significant demand for myopia and presbyopia treatment market during the forecast period.

Rise in geriatric population prone to vision loss and the number of individuals above 40 years of age across the globe is projected to fuel the market growth. Most adults, in their mid-40s, start developing age-related eye diseases, thus augmenting the demand for myopia and presbyopia treatment.

Undiagnosed presbyopia is one of the primary issues that will have a significant influence on the vision care sector. The pathogenesis of presbyopia is still unknown, resulting in delayed diagnosis and higher treatment expenses. The introduction of sophisticated lenses like intraocular phakic presbyopia lenses and implantable contact lenses is projected to fuel market expansion. These lenses can correct substantial nearsightedness, minimise the risk of dry eyes, can be surgically removed, and are appropriate for non-LASIK patients. Such benefits are expected to drive demand in the near future.

The market is classified into three types of myopia treatment: corrective, surgical, and medicines. The corrective section is subdivided further into prescription and contact lenses. The most common types of corrective prescription treatments are single, bifocal, and trifocal. Implantable contact lenses are a type of contact lens. Laser-Assisted In Situ Keratomileusis (LASIK), Laser Epithelial Keratomileusis (LASEK), and Photorefractive Keratectomy are surgical procedures (PRK). Due to the rising prevalence of myopia in emerging nations, the single prescription lenses segment represented the highest proportion of the myopia and presbyopia treatment market in 2018. A larger patient pool is expected to contribute to an increase in demand for corrective lenses.